UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.682

Sortiert nach

Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma

Clinical cancer research, 2009-04, Vol.15 (8), p.2818-2828

2009

Volltextzugriff (PDF)

Histone deacetylase–mediated transcriptional activation reduces proviral loads in HTLV-1–associated myelopathy/tropical spastic paraparesis patients

Blood, 2007-11, Vol.110 (10), p.3722-3728

2007

Volltextzugriff (PDF)

Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer

European journal of pharmacology, 2018-09, Vol.835, p.61-74

2018

Volltextzugriff (PDF)

Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response

Experimental hematology, 2007-10, Vol.35 (10), p.1527-1537

2007

Volltextzugriff (PDF)

Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (29), p.10309-10314

2005

Volltextzugriff (PDF)

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile

Molecules (Basel, Switzerland), 2021-12, Vol.27 (1), p.104

2021

Volltextzugriff (PDF)

Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth

Biomaterials, 2018-06, Vol.167, p.69-79

2018

Volltextzugriff (PDF)

Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

Current neuropharmacology, 2019-01, Vol.17 (10), p.926-946

2019

Volltextzugriff (PDF)

Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest

ACS nano, 2014-03, Vol.8 (3), p.2134-2147

2014

Volltextzugriff (PDF)

Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism

Pharmacology, biochemistry and behavior, 2014-11, Vol.126, p.43-49

2014

Volltextzugriff (PDF)

Hidden pharmacological activities of valproic acid: A new insight

Biomedicine & pharmacotherapy, 2021-10, Vol.142, p.112021, Article 112021

2021

Volltextzugriff (PDF)

Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation

Leukemia, 2019-04, Vol.33 (4), p.945-956

2019

Volltextzugriff (PDF)

Histone Deacetylation Inhibition in Pulmonary Hypertension Therapeutic Potential of Valproic Acid and Suberoylanilide Hydroxamic Acid

Circulation (New York, N.Y.), 2012-07, Vol.126 (4), p.455-467

2012

Volltextzugriff (PDF)

Lithium increases mitochondrial respiration in iPSC-derived neural precursor cells from lithium responders

Molecular psychiatry, 2021-11, Vol.26 (11), p.6789-6805

2021

Volltextzugriff (PDF)

The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy

Scientific reports, 2016-11, Vol.6 (1), p.36250-36250, Article 36250

2016

Volltextzugriff (PDF)

The pharmacogenomics of valproic acid

Journal of human genetics, 2017-12, Vol.62 (12), p.1009-1014

2017

Volltextzugriff (PDF)

Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice

Psychopharmacology, 2024-02, Vol.241 (2), p.327-340

2024

Volltextzugriff (PDF)

Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats

Brain research bulletin, 2019-04, Vol.147, p.36-46

2019

Volltextzugriff (PDF)

SHANK3 overexpression causes manic―like behaviour with unique pharmacogenetic properties

Nature (London), 2013-11, Vol.503 (7474), p.72-77

2013

Volltextzugriff (PDF)

Sodium valproate treatment reverses endothelial dysfunction in aorta from rabbits with acute myocardial infarction

European journal of pharmacology, 2024-05, Vol.970, p.176475-176475, Article 176475

2024

Volltextzugriff (PDF)

Photo-uncaging of BODIPY oxime ester for histone deacetylases induced apoptosis in tumor cells

Chemical communications (Cambridge, England), 2019-12, Vol.55 (94), p.14162-14165

2019

Volltextzugriff (PDF)

HPLC-UV and GC-MS Methods for Determination of Chlorambucil and Valproic Acid in Plasma for Further Exploring a New Combined Therapy of Chronic Lymphocytic Leukemia

Molecules (Basel, Switzerland), 2021-05, Vol.26 (10), p.2903

2021

Volltextzugriff (PDF)

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma

Clinical cancer research, 2012-01, Vol.18 (2), p.408-416

2012

Volltextzugriff (PDF)

Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer

The FEBS journal, 2020-05, Vol.287 (10), p.2118-2133

2020

Volltextzugriff (PDF)

Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring

Science (American Association for the Advancement of Science), 2014-02, Vol.343 (6171), p.675-679

2014

Volltextzugriff (PDF)

1 – 25 von 7.682

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Psychopharmacology

SpracheDänisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.038)
Mit Volltextzugriff
(5.830)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.769)
Life Sciences & Biomedicine
(6.575)
Humans
(4.624)
Valproic Acid - Pharmacology
(3.724)
Male
(3.519)
Animals
(3.368)
Biological And Medical Sciences
(3.282)
Medical Sciences
(3.165)
Pharmacology. Drug Treatments
(2.860)
Valproic Acid
(2.822)
Pharmacology & Pharmacy
(2.807)
Female
(2.770)
Neurosciences & Neurology
(2.311)
Valproic Acid - Therapeutic Use
(2.026)
Neuropharmacology
(1.820)
Rats
(1.636)
Adult
(1.577)
Clinical Neurology
(1.370)
Neurosciences
(1.328)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(1.267)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Epilepsia
(391)
Therapeutic Drug Monitoring
(149)
Epilepsy Research
(133)
The Journal Of Clinical Psychiatry
(112)
Plos One
(111)
European Journal Of Pharmacology
(106)
Neurology
(104)
Neuropharmacology
(91)
Epilepsia : Journal Of The International League Against Epilepsy
(88)
Brain Research
(79)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma

Histone deacetylase–mediated transcriptional activation reduces proviral loads in HTLV-1–associated myelopathy/tropical spastic paraparesis patients

Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer

Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response

Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile

Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth

Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest

Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism

Hidden pharmacological activities of valproic acid: A new insight

Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation

Histone Deacetylation Inhibition in Pulmonary Hypertension Therapeutic Potential of Valproic Acid and Suberoylanilide Hydroxamic Acid

Lithium increases mitochondrial respiration in iPSC-derived neural precursor cells from lithium responders

The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy

The pharmacogenomics of valproic acid

Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice

Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats

SHANK3 overexpression causes manic―like behaviour with unique pharmacogenetic properties

Sodium valproate treatment reverses endothelial dysfunction in aorta from rabbits with acute myocardial infarction

Photo-uncaging of BODIPY oxime ester for histone deacetylases induced apoptosis in tumor cells

HPLC-UV and GC-MS Methods for Determination of Chlorambucil and Valproic Acid in Plasma for Further Exploring a New Combined Therapy of Chronic Lymphocytic Leukemia

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma

Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer

Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring

Aktive Filter

Suchergebnisse filtern